Skip to main content

Table 4 Results from regression adjustment (RA), propensity score matching (PSM), and instrumental variable analysis models (IV) for effects of baseline SNI on various subsequent adult health outcomes for the total sample and stratified by sex/gender

From: Effects of social network diversity in the disablement process: a comparison of causal inference methods and an outcome-wide approach to the Indonesian Family Life Surveys, 2007–2015

Health outcomes

Total sample (n = 3060)

Women (n = 1583, 52%)

Men (n = 1477, 48%)

RA

PSM

IV

RA

PSM

IV

RA

PSM

IV

Coef

p

ATT

p

LATE

p

Coef

p

ATT

p

LATE

p

Coef

p

ATT

p

LATE

p

NCD morbidity

0.12

0.411

0.029

0.480

−0.146

0.499

0.26

0.126

0.029

0.052

−0.672

0.447

−0.04

0.633

0.004

0.904

−0.013

0.950

Asthma

0.19

0.410

0.008

0.383

0.070

0.502

0.69

0.018

0.023

0.002

−0.118

0.729

− 0.34

0.196

− 0.007

0.171

0.146

0.196

Other lung diseases

0.83

0.002

0.020

0.001

0.089

0.315

1.07

0.009

0.020

0.000

− 0.019

0.940

0.63

0.103

0.013

0.064

0.111

0.262

Cancer, malignant tumours

−0.93

0.050

− 0.004

0.082

− 0.084

0.123

− 0.95

0.142

− 0.006

0.179

− 0.165

0.424

−0.87

0.213

−0.006

0.234

−0.062

0.224

Diabetes

−0.04

0.296

0.004

0.370

0.078

0.590

0.04

0.517

0.006

0.882

0.389

0.478

−0.13

0.357

0.010

0.985

−0.039

0.792

Cardiovascular diseases

0.34

0.048

0.018

0.134

−0.114

0.362

0.27

0.177

0.014

0.104

−0.165

0.669

0.43

0.128

0.016

0.224

−0.103

0.427

Stroke

0.05

0.844

−0.001

0.862

−0.019

0.829

−0.09

0.859

−0.001

0.805

−0.538

0.309

0.12

0.774

−0.009

0.605

0.129

0.223

HbA1c levels

−0.10

0.988

0.041

0.837

0.842

0.829

0.18

0.970

0.060

0.732

−1.202

0.492

0.04

0.972

−0.030

0.770

0.052

0.927

Hypertension

0.03

0.155

0.004

0.115

0.466

0.138

−0.08

0.594

−0.025

0.914

0.981

0.408

0.12

0.232

0.026

0.201

0.301

0.331

CRP levels

−0.21

0.063

−0.131

0.002

1.908

0.746

−0.09

0.247

−0.152

0.011

−1.249

0.480

−0.32

0.192

−0.065

0.214

0.088

0.351

Grip strengths

0.19

0.364

0.330

0.068

−2.959

0.370

0.07

0.806

−0.260

0.890

−6.162

0.524

0.38

0.246

0.464

0.326

−2.099

0.578

Arthritis/rheumatism

−0.02

0.808

−0.009

0.695

−0.359

0.113

−0.05

0.717

0.003

0.739

−1.061

0.350

0.07

0.910

0.008

0.627

−0.177

0.343

Sensory impairments

−0.09

0.576

−0.005

0.660

0.107

0.563

−0.12

0.531

−0.023

0.271

0.564

0.455

−0.04

0.990

−0.010

0.740

0.014

0.938

Upper-body functional limitations

0.17

0.014

0.041

0.011

−0.431

0.157

0.24

0.004

0.074

0.016

−1.261

0.380

0.18

0.199

0.032

0.364

−0.208

0.427

Lower-body functional limitations

0.12

0.166

0.047

0.133

−0.195

0.492

0.27

0.016

0.073

0.004

−0.450

0.643

−0.07

0.487

0.004

0.854

−0.163

0.551

Episodic memory

0.09

0.062

0.112

0.206

5.144

0.002

0.06

0.283

0.043

0.523

6.404

0.051

0.12

0.130

0.070

0.207

4.175

0.020

Visuospatial abilities

−0.04

0.967

−0.035

0.855

6.199

0.003

−0.12

0.266

−0.080

0.465

4.983

0.028

0.08

0.208

0.063

0.193

7.728

0.058

ADL limitations

0.19

0.000

0.187

0.000

−0.532

0.501

0.26

0.000

0.220

0.000

−5.053

0.334

0.10

0.112

0.177

0.011

0.842

0.270

IADL limitations

0.56

0.000

0.500

0.003

−4.283

0.096

0.66

0.000

0.473

0.000

−13.602

0.327

0.39

0.050

0.492

0.033

−1.812

0.432

  1. Note: Coef Regression coefficients, ATT Average treatment effects, LATE Local average treatment effects, p p-value (significant results are printed in bold)